Funder
National Institute of Health (NIH/NIDCR)
Lawrence Berkeley National Laboratory (LBNL)
National Institutes of Health
Swiss National Science Foundation
DFG-Emmy Noether
Research Facilities Improvement Program
National Center for Research Resources, National Institutes of Health
Office of Science of the U.S. Department of Energy
Subject
Histology,Physiology,Endocrinology, Diabetes and Metabolism
Reference57 articles.
1. Bone density around endosseous implants in patients taking alendronate: a pilot study;Griffiths;Int. J. Periodontics Restorative Dent.,2012
2. Bisphosphonates: the first 40years;Russell;Bone,2011
3. Severely suppressed bone turnover: a potential complication of alendronate therapy;Odvina;J. Clin. Endocrinol. Metab. Endocr. Soc.,2005
4. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution;Goh;J. Bone Joint Surg. (Br.),2007
5. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate;Lenart;N. Engl. J. Med.,2008
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献